📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Biomarker Predictors of Clinical Efficacy of the Anti-IgE Biologic Omalizumab in Severe Asthma in Adults: Results of the SoMOSA Study. (2024)

First Author: Djukanovic R

Attributed to: High Resolution Mass Spectrometer to support Proteomic Research across the Southern 4 Proteomic Consortium funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1164/rccm.202310-1730oc

PubMed Identifier: 38635834

Publication URI: http://europepmc.org/abstract/MED/38635834

Type: Journal Article/Review

Volume: 210

Parent Publication: American journal of respiratory and critical care medicine

Issue: 3

ISSN: 1073-449X